February 19, 2017 2:36 PM ET


Company Overview of Biolex Therapeutics, Inc.

Company Overview

On August 25, 2014, Biolex Therapeutics, Inc. went out of business as per its Chapter 7 liquidation filing under bankruptcy. Biolex Therapeutics, Inc. operates as a biopharmaceutical company. It offers Locteron, a controlled-release interferon alfa for the treatment of hepatitis C; BLX-155, a thrombolytic or clot buster to dissolve blood clots; and BLX-301, an antibody for the treatment of B-cell lymphoma. Biolex Therapeutics, Inc. has a research and development collaboration with Merial Limited to produce veterinary vaccines. The company was formerly known as Biolex, Inc. and changed its name to Biolex Therapeutics, Inc. in November, 2007. The company was founded in 1997 and is based in Pit...

158 Credle Street

Pittsboro, NC 27312

United States

Founded in 1997

106 Employees





Key Executives for Biolex Therapeutics, Inc.

Biolex Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biolex Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.